4 Factors That Impact The Diagnosis Of Prostate Cancer
4 factors that impact the diagnosis of prostate cancer
Prostate cancer is one of the most common kinds of cancers diagnosed among men around the world. The prostate is a small-sized male gland that resembles a walnut and plays a pivotal role in the nourishment and transportation of sperm. Prostate cancer is triggered when there is an abnormal growth of cancerous cells in the prostate. In the beginning, cancer grows at a very gradual pace and is confined within the gland. During this course, an individual does not face a huge risk. However, when the growth is uncontrolled and spreads aggressively, there may be grave repercussions.
Prostate cancer can be of numerous types, and the aggressive kind spreads much faster as compared to the rest. The condition is commonly detected among older males and is rare in men younger than the age of 40. The thought of being diagnosed with any kind of cancer can be overwhelming. However, dealing with the condition is easier if diagnosed in the initial stages. Here are four factors that impact the diagnosis of the disease:
What are the symptoms exhibited in prostate cancer?
Typically, there may be no symptoms experienced with prostate cancer in the early stages. However, as the condition progresses, some individuals may experience:
- Inability to control urination
- Traces of blood in the urine
- Pain during urination
- Discomfort during ejaculation
- Bone fractures
- Pain in the spine, pelvis, and ribs
What are the drawbacks associated with the genetic screening for prostate cancer?
- It is indubitable that genetic screening for prostate cancer comes with numerous benefits, not only during the diagnosis but also in the personalization of treatment. However, there are several questionable factors about the usage of the genetic screening methods.
- Genetic screening for prostate cancer is available only for men who have a history of prostate, breast or ovarian cancer within the family.
- The genetic screening does not always provide a definite answer about the risk of cancer. In some cases, the results may not be able to divulge any additional information about the risk of family members suffering from the condition.
- The procedure of prostate cancer genetic screening can be expensive and is commonly not covered by insurance.
How can genetic counseling aid in the process of prostate cancer genetic screening?
The decision of undergoing a genetic screening for prostate cancer can be an extremely hard one. However, it can be a doorway to relevant health information, and genetic counseling can aid in the process.
- Genetic counseling can help people evaluate whether they need the test and why it would be necessary.
- It enlightens an individual about the type of genetic screening for prostate cancer.
- The counseling session shed light on the risks and implications of the procedure while helping individuals consider the impact.
- Genetic counseling also helps the family deal with the pressure and prevent the feeling of regret among people who get a positive result.
- Importantly, families are notified about any new information and research opportunities related to the condition.
What are the steps to be taken if the prostate cancer genetic screening result is positive?
While the information can disturb one’s mental peace, it is vital to know that some steps can be taken to manage the risk.
- An individual must speak with the doctor to find out about different ways to lower one’s risk of developing prostate cancer. The physician may be able to devise a hormonal therapy to reduce the possibilities.
- One will have to weigh the pros and cons of the oral contraceptive and whether he is eligible to consume the same given the overall health factors.
- The individual should undergo a medical screening and clinical exams more frequently, i.e., at least once in six months.
- One can take preventive measures including surgical methods to disrupt the formation of cancer.
- The family must alter their lifestyle habits and make other decisions to help lower the risk of prostate cancer.